| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/01/2023 | Harpoon Therapeutics, Inc. | HARP | Grant | Common Stock | 3k | $0.00 | $0 | | 10/01/2023 |
| 07/01/2023 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Share Units | 2.8k | $0.00 | $0 | | 07/01/2023 |
| 07/01/2023 | Harpoon Therapeutics, Inc. | HARP | Grant | Common Stock | 18.7k | $0.00 | $0 | | 07/01/2023 |
| 05/17/2023 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 15.5k | $5.64 | $87.4k | | 05/17/2023 |
| 04/01/2023 | Harpoon Therapeutics, Inc. | HARP | Grant | Common Stock | 18.3k | $0.00 | $0 | | 04/01/2023 |
| 04/01/2023 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Share Units | 2k | $0.00 | $0 | | 04/01/2023 |
| 03/23/2023 | Harpoon Therapeutics, Inc. | HARP | Purchase | 8.000% Series A Redeemable Preferred Stock | 10k | $1,000.00 | $10M | See Footnote | 03/23/2023 |
| 03/23/2023 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common Stock Warrant (Right to Buy) | 3M | $0.98 | $2.9M | See Footnote | 03/23/2023 |
| 01/03/2023 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 11.1k | $6.19 | $68.7k | | 01/03/2023 |
| 01/01/2023 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Share Units | 1.2k | $0.00 | $0 | | 01/01/2023 |
| 12/23/2022 | Iterum Therapeutics plc | ITRM | Grant | Restricted Share Units | 5.5k | $0.00 | $0 | | 12/23/2022 |
| 09/25/2022 | Iterum Therapeutics plc | ITRM | Grant | Restricted Share Units | 2.8k | $0.00 | $0 | | 09/25/2022 |
| 06/25/2022 | Iterum Therapeutics plc | ITRM | Grant | Restricted Share Units | 30.6k | $0.00 | $0 | | 06/25/2022 |
| 06/23/2022 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Share Units | 36.8k | $0.00 | $0 | | 06/23/2022 |
| 06/22/2022 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $2.01 | $20.4k | | 06/22/2022 |
| 06/22/2022 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 32.1k | $2.01 | $64.6k | | 06/22/2022 |
| 06/15/2022 | Iterum Therapeutics plc | ITRM | Grant | Share Option (Right to Buy) | 647.1k | $0.21 | $135.9k | | 06/15/2022 |
| 05/24/2022 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 13.4k | $12.75 | $171.4k | | 05/24/2022 |
| 03/25/2022 | Iterum Therapeutics plc | ITRM | Grant | Restricted Share Units | 18k | $0.00 | $0 | | 03/25/2022 |
| 01/03/2022 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 6.2k | $10.38 | $64.8k | | 01/03/2022 |
| 08/02/2021 | Rallybio Corp | RLYB | Purchase | Common Stock | 153.8k | $13.00 | $2M | See footnote | 07/28/2021 |
| 08/02/2021 | Rallybio Corp | RLYB | Purchase | Common Stock | 153.8k | $13.00 | $2M | See footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series A-1 Preferred Units | 1.8M | $0.00 | $0 | See footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series A-2 Preferred Units | 8.7M | $0.00 | $0 | See footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series B Preferred Units | 2.2M | $0.00 | $0 | See footnote | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 13.4k | $13.00 | $174.7k | | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (acquisition) | Common Stock | 2M | $0.00 | $0 | See footnote | 07/28/2021 |
| 06/23/2021 | Iterum Therapeutics plc | ITRM | Grant | Restricted Stock Units | 36.8k | $0.00 | $0 | | 06/23/2021 |
| 05/04/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $0.00 | $0 | | 05/04/2021 |
| 05/04/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 4.7k | $0.00 | $0 | | 05/04/2021 |
| 05/04/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 4.8k | $22.50 | $108.2k | | 05/04/2021 |
| 05/04/2021 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $22.50 | $228.8k | | 05/04/2021 |
| 01/11/2021 | Harpoon Therapeutics, Inc. | HARP | Purchase | Common Stock | 235.3k | $17.00 | $4M | See footnote | 01/11/2021 |
| 07/01/2020 | Iterum Therapeutics plc | ITRM | Exercise | Restricted Stock Units | 5.7k | $0.00 | $0 | | 07/01/2020 |
| 05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $20.59 | $209.3k | | 05/28/2020 |
|